Showing results (1561-1570 of 2,166) with videos related to

Sort By:
Pageof 217
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 2, 2023
Doubly Bridged Anthracenes: Blue Emitters for OLEDsPhilipp Ludwig, Jacob Mayer, Lukas Ahrens, et al.
Blood|August 15, 2002
Cyclosporine inhibition of P-glycoprotein in chronic myeloid leukemia blast phaseAlan F List, Kenneth J Kopecky, Cheryl L Willman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2001
Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancerC A Mantz, E E Vokes, M S Kies, et al.
The Oncologist|April 12, 2011
Perceptions of disease state, treatment outcomes, and prognosis among patients with myelodysplastic syndromes: results from an internet-based surveyMikkael A Sekeres, Jaroslaw P Maciejewski, Alan F List, et al.
Proteomics|March 29, 2007
Analysis of mouse skin reveals proteins that are altered in a diet-induced diabetic state: a new method for detection of type 2 diabetesEdward O List, Darlene E Berryman, Amanda J Palmer, et al.
Diabetes Care|October 2, 2014
Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot studyRobert R Henry, Julio Rosenstock, Steven Edelman, et al.
British Journal of Haematology|April 29, 2006
Mutations of the myeloid transcription factor CEBPA are not associated with the blast crisis of chronic myeloid leukaemiaThomas Pabst, Erica Stillner, Donna Neuberg, et al.
Physical Chemistry Chemical Physics : PCCP|June 30, 2009
Ion beam degradation analysis of poly(3-hexylthiophene) (P3HT): can cryo-FIB minimize irradiation damage?Meltem Sezen, Harald Plank, Philipp M Nellen, et al.
Blood|April 30, 2008
Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programsDana E Rollison, Nadia Howlader, Martyn T Smith, et al.
Cancer Research|July 5, 2012
HG-829 is a potent noncompetitive inhibitor of the ATP-binding cassette multidrug resistance transporter ABCB1Gisela Caceres, Robert W Robey, Lubomir Sokol, et al.
Pageof 217